Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Implementing long-read sequencing for clinical detection of sepsis pathogens and resistance genes
EF 2025-26
Résumé
Sepsis is a life-threatening response to infection that kills millions of people every year, and low-income countries bear the highest burden. Young infants are especially vulnerable. Sepsis symptoms can be hard to spot, but they can progress quickly to cause long-term organ and/or immune system damage, and death. Quick and accurate diagnosis of sepsis is critical; every hourlong delay of treatment can increase the risk of severe illness or death. However, current blood culture tests often fail to detect bacteria causing infection, and it can take several days to know if the infection will respond to antibiotics. This leaves doctors with no choice but to use general antibiotics, which can lead to treatment failure and drive antibiotic resistance.
My project will evaluate new tests to detect sepsis using emerging DNA-reading technology. The first test uses PCR to detect and identify bacterial DNA in small blood samples. The second test sequences DNA directly from positive blood cultures to detect genes that make bacteria resistant to specific antibiotics. Both methods will be tested on samples from infants and children with suspected sepsis, DNA will be run on a new sequencing platform, and results compared to culture-based diagnostic tests to see how accurate and useful these new methods could be in clinical practice. If accurate, such tests could be faster than conventional blood culture tests used today.
Faster and reliable sepsis diagnostic tests could transform sepsis diagnosis in children and save lives by allowing doctors to choose the most effective treatments sooner and reduce the use of unnecessary antibiotics in children. It could also reduce the risk of long-term complications, shorten hospital stays, and lessen the emotional burden of families.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572799
Name
Makhanko-Tang Claudia
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Implementing long-read sequencing for clinical detection of sepsis pathogens and resistance genes
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Antimicrobial Resistance Profiling; Clinical Microbiology; Metagenomics; Molecular Diagnostics; Oxford Nanopore Sequencing; Pediatric Sepsis; Point-Of-Care Diagnostics; Precision Diagnostics; Rapid Pathogen Identification; Translational Medicine
Abstract
Sepsis is a life-threatening response to infection that kills millions of people every year, and low-income countries bear the highest burden. Young infants are especially vulnerable. Sepsis symptoms can be hard to spot, but they can progress quickly to cause long-term organ and/or immune system damage, and death. Quick and accurate diagnosis of sepsis is critical; every hourlong delay of treatment can increase the risk of severe illness or death. However, current blood culture tests often fail to detect bacteria causing infection, and it can take several days to know if the infection will respond to antibiotics. This leaves doctors with no choice but to use general antibiotics, which can lead to treatment failure and drive antibiotic resistance.
My project will evaluate new tests to detect sepsis using emerging DNA-reading technology. The first test uses PCR to detect and identify bacterial DNA in small blood samples. The second test sequences DNA directly from positive blood cultures to detect genes that make bacteria resistant to specific antibiotics. Both methods will be tested on samples from infants and children with suspected sepsis, DNA will be run on a new sequencing platform, and results compared to culture-based diagnostic tests to see how accurate and useful these new methods could be in clinical practice. If accurate, such tests could be faster than conventional blood culture tests used today.
Faster and reliable sepsis diagnostic tests could transform sepsis diagnosis in children and save lives by allowing doctors to choose the most effective treatments sooner and reduce the use of unnecessary antibiotics in children. It could also reduce the risk of long-term complications, shorten hospital stays, and lessen the emotional burden of families.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Makhanko-Tang, Claudia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~